1. Home
  2. VRPX

VRPX

Virpax Pharmaceuticals Inc.

Logo Virpax Pharmaceuticals Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-18-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Founded: N/A Country:
United States
United States
Employees: N/A City: BERWYN
Market Cap: 4.1M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 24.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -12.97 EPS Growth: N/A
52 Week Low/High: $2.40 - $11.77 Next Earning Date: 05-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: